Update: GFI Board Rejects BGC Offer
BGC insists its offer still stands.
The latest salvo in the long-running battle between GFI ─ which initially announced that it would be acquired by the Chicago Mercantile Exchange (CME) Group in July ─ and BGC means that the offer is open to shareholders without the support of the company's management. BGC had previously entered into negotiations over its offer, which values the company at $5.25 per share, but turned it hostile after it accused GFI's board of not negotiating in good faith. GFI, for its part, describes BGC's advances as "unsolicited", and says that the board still supports the original deal with CME Group.
Recommendations from the committee for rejecting the offer centered on the likelihood of the deal being consummated, which it said was much higher with the original CME deal than the offer presented by BGC, which currently owns 13.5 percent of the firm.
"The board carefully considered the unanimous determination and recommendation of the special committee of the board to reject the offer after consultation with its independent financial advisor and outside legal counsel," says GFI, in a statement posted to its investor relations website. "The special committee and the board determined that the offer is highly conditional and is not in the best interests of GFI or its stockholders. Accordingly, the board recommends that GFI stockholders reject the offer and not tender their shares into the offer."
GFI has published the recommendations of the special committee and its reasoning in a Schedule 14D-9 filing with the US Securities and Exchange Commission. There was no immediate public comment from either BGC Partners or the CME Group. However, in an interview with Reuters published yesterday, CME chairman Terry Duffy expressed optimism that Trayport and Fenics, the technology products owned by GFI at the heart of the tussle, would be available no matter the outcome of the spat.
Update (November 6): BGC Partners has released a statement saying that its offer for GFI still stands up to the closing date of November 19, by which shareholders must respond. The firm reinforced its belief that the higher price value placed on the CME offer of $4.55 per share constitutes a superior offer, but said that it would amend aspects of its proposal to counter the objections put forward by GFI's special committee.
"We are confident that GFI's outside shareholders will view BGC's fully financed, $5.25 per share all-cash tender offer as superior to the $4.55 per share all-stock transaction with CME," says Howard Lutnick, chairman and CEO of BGC. "We remain committed to completing our tender, which provides a higher all-cash price, and which has closing conditions offering BGC protections substantially similar to the protections offered to CME by GFI."
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe
You are currently unable to print this content. Please contact info@waterstechnology.com to find out more.
You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email info@waterstechnology.com
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email info@waterstechnology.com
More on Emerging Technologies
FactSet looks to build on portfolio commentary with AI
Its new solution will allow users to write attribution summaries more quickly and adds to its goal of further accelerating discoverability, automation, and innovation.
How Ally found the key to GenAI at the bottom of a teacup
Risk-and-tech chemistry—plus Microsoft’s flexibility—has seen the US lender leap from experiments to execution.
The IMD Wrap: Beginning of the end for data audits?
This week, there’s exciting news for data bean-counters in the form of a partnership between two vendors that could change the way we view and track data usage and audits.
S&P debuts Spark Assist genAI copilot, draws up ‘Blueprints’ of combined datasets
S&P’s Kensho subsidiary has rolled out new emerging tech products leveraging AI to explore and combine the vendor’s wealth of datasets to solve common use cases.
Nasdaq reshuffles tech divisions post-Adenza
Adenza is now fully integrated into the exchange operator’s ecosystem, bringing opportunities for new business and a fresh perspective on how fintech fits into its strategy.
Liquidnet sees electronic future for gray bond trading
TP Icap’s gray market bond trading unit has more than doubled transactions in the first quarter of 2024.
Verafin launches genAI copilot for fincrime investigators
Features include document summarization and improved research tools.
Waters Wrap: Open source and storm clouds on the horizon
Regulators and politicians in America and Europe are increasingly concerned about AI—and, by extension, open-source development. Anthony says there are real reasons for concern.
Most read
- Chris Edmonds takes the reins at ICE Fixed Income and Data Services
- Deutsche Börse democratizes data with Marketplace offering
- Nasdaq reshuffles tech divisions post-Adenza